银屑病关节炎与银屑病患者心脏生物标志物与心血管结局的关联:一项纵向队列研究
在1000例银屑病患者中,358例基线测量颈动脉总斑块面积,64例发生心血管事件。调整心血管危险因素后,心肌肌钙蛋白I与颈动脉总斑块面积仍显著相关,N末端脑钠肽前体不显著;两种标志物均与心血管事件相关且独立于Framingham风险评分,但未改善预测性能。
要点
- 调整心血管危险因素后,心肌肌钙蛋白I与颈动脉总斑块面积仍显著相关(校正β系数0.21,P=0.047)。
- N末端脑钠肽前体与颈动脉总斑块面积的关联在校正后未达统计学显著(P=0.21)。
- 在Framingham风险评分基础上加入心脏生物标志物未改善心血管事件预测性能。
核心结论
- 在银屑病患者中,心肌肌钙蛋白I可能反映动脉粥样硬化负荷,且独立于传统心血管危险因素。
- 心肌肌钙蛋白I和N末端脑钠肽前体与心血管事件相关且独立于Framingham风险评分,但需进一步研究其在心血管风险分层中的作用。
研究设计与样本
- 纵向队列研究,纳入1000例银屑病患者评估心血管风险预测,其中358例在基线测量颈动脉总斑块面积。
- 使用自动化临床检测方法测量心肌肌钙蛋白I和N末端脑钠肽前体。
- 采用多变量回归评估生物标志物与颈动脉粥样硬化的关联,并检验在Framingham风险评分基础上对心血管事件预测的改善。
主要发现
- 单变量分析中,心肌肌钙蛋白I与颈动脉总斑块面积相关(β系数0.52,95%CI 0.3至0.74,P<0.001)。
- 单变量分析中,N末端脑钠肽前体与颈动脉总斑块面积相关(β系数0.24,95%CI 0.1至0.39,P<0.001)。
- 调整心血管危险因素后,心肌肌钙蛋白I与颈动脉总斑块面积的关联仍显著(校正β系数0.21,95%CI 0至0.41,P=0.047),N末端脑钠肽前体不显著(P=0.21)。
- 1000例患者中64例发生心血管事件;与仅含Framingham风险评分的基础模型相比,加入心脏生物标志物的扩展模型预测性能无改善。
关键数值与推荐
- 心肌肌钙蛋白I单变量β系数0.52(95%CI 0.3至0.74,P<0.001),校正后β系数0.21(95%CI 0至0.41,P=0.047)。
- N末端脑钠肽前体单变量β系数0.24(95%CI 0.1至0.39,P<0.001),校正后P=0.21。
- 1000例银屑病患者中64例发生心血管事件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出需进一步研究心肌肌钙蛋白I和N末端脑钠肽前体在心血管风险分层中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In patients with psoriatic disease (PsD), we determined whether cardiac troponin I (cTnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) were associated with carotid plaque burden and the development of cardiovascular events independent of the Framingham Risk Score (FRS). METHODS: Among 1,000 patients with PsD, carotid total plaque area (TPA) was measured in 358 participants at baseline. Cardiac troponin I and NT-proBNP were measured using automated clinical assays. The association between cardiac biomarkers and carotid atherosclerosis was assessed by multivariable regression after adjusting for cardiovascular risk factors. Improvement in the prediction of cardiovascular events beyond the FRS was tested using measures of risk discrimination and reclassification. RESULTS: In univariate analyses, cTnI (β coefficient 0.52 [95% confidence interval (95% CI) 0.3, 0.74], P < 0.001) and NT-proBNP (β coefficient 0.24 [95% CI 0.1, 0.39], P < 0.001) were associated with TPA. After adjusting for cardiovascular risk factors, the association remained statistically significant for cTnI (adjusted β coefficient 0.21 [95% CI 0, 0.41], P = 0.047) but not for NT-proBNP (P = 0.21). Among the 1,000 patients with PsD assessed for cardiovascular risk prediction, 64 patients had incident cardiovascular events. When comparing a base model (with the FRS alone) to expanded models (with the FRS plus cardiac biomarkers), there was no improvement in predictive performance. CONCLUSION: In patients with PsD, cTnI may reflect the burden of atherosclerosis, independent of traditional cardiovascular risk factors. Cardiac troponin I and NT-proBNP are associated with incident cardiovascular events independent of the FRS, but further study of their role in cardiovascular risk stratification is warranted.
引用
- Colaco K, Lee KA, Akhtari S, et al. Association of Cardiac Biomarkers With Cardiovascular Outcomes in Patients With Psoriatic Arthritis and Psoriasis: A Longitudinal Cohort Study. Arthritis Rheumatol. 2022. PMID: 35261189. doi:10.1002/art.42079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。